(Total Views: 573)
Posted On: 07/15/2020 10:12:39 PM
Post# of 148949
Patterson has never wavered on the PII
I
I'm betting the m/m results are going to be good, as leronlimab prevents the disease from progressing from the viral stage to the immunological stage, but 20% of placebo arm do not improve => good evidence of effectiveness.
Read More: https://investorshangout.com/post/view?id=582...z6SJsfQgxD
I too thought the PII the easier hurdle.
I am certain Patterson knows the answer to every one of these measures
- I bet he could recite in his sleep:
Other Outcome Measures:
Change from baseline in serum cytokine and chemokine levels [ Time Frame: Days 3, 7, and 14 ]
Change from baseline in CCR5 receptor occupancy levels for Tregs and macrophages [ Time Frame: Days 3, 7, and 14 ]
Change from baseline in CD3+, CD4+ and CD8+ T cell count [ Time Frame: Days 3, 7, and 14 ]
I
I'm betting the m/m results are going to be good, as leronlimab prevents the disease from progressing from the viral stage to the immunological stage, but 20% of placebo arm do not improve => good evidence of effectiveness.
Read More: https://investorshangout.com/post/view?id=582...z6SJsfQgxD
I too thought the PII the easier hurdle.
I am certain Patterson knows the answer to every one of these measures
- I bet he could recite in his sleep:
Other Outcome Measures:
Change from baseline in serum cytokine and chemokine levels [ Time Frame: Days 3, 7, and 14 ]
Change from baseline in CCR5 receptor occupancy levels for Tregs and macrophages [ Time Frame: Days 3, 7, and 14 ]
Change from baseline in CD3+, CD4+ and CD8+ T cell count [ Time Frame: Days 3, 7, and 14 ]
(0)
(0)Scroll down for more posts ▼
